Drug intelligence / Profile preview

hyaluronic acid + platelet rich plasma

Development stage
Unknown
Lead developer
University of Karachi
Modality
Cell Therapies
Administration
Intraarticular
01

Overview

This combination therapy consists of **Hyaluronic Acid (HA)** and **Platelet-Rich Plasma (PRP)**, which is being evaluated for the treatment of knee osteoarthritis. Hyaluronic acid acts as a viscosupplement, providing mechanical lubrication and shock absorption within the joint to compensate for the loss of synovial fluid quality. Platelet-Rich Plasma is an autologous blood product containing a high concentration of platelets that, upon activation, release various growth factors (such as TGF-β, PDGF, and VEGF) and cytokines. These factors promote tissue repair, stimulate chondrocyte proliferation, and modulate the inflammatory environment of the joint. The combination is hypothesized to have a synergistic effect, where HA improves the joint's physical environment while PRP stimulates biological regenerative processes. A specific study by the **University of Karachi** (NCT04133103) has investigated this combination in patients with Grade II-III knee osteoarthritis.

Other names
HA + PRPHyaluronic Acid and Platelet rich plasma

Beyond the preview

Go deeper on hyaluronic acid + platelet rich plasma.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hyaluronic acid + platelet rich plasma.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call